Suppr超能文献

横川-san:该汉方药在痴呆和精神疾病中的应用证据综述。

Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.

机构信息

Department of Japanese-Oriental (Kampo) Medicine Chiba University Graduate School of Medicine, Chiba City, Japan ; Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba City, Japan.

Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba City, Japan.

出版信息

Neuropsychiatr Dis Treat. 2014 Sep 12;10:1727-42. doi: 10.2147/NDT.S65257. eCollection 2014.

Abstract

Japanese traditional herbal medicine (Kampo) has its origins in traditional Chinese medicine (TCM). It was introduced to Japan in the middle of the sixth century and has evolved over the past 1,400 years after combining with Japan's original folk remedies. While it retains some similarities to TCM, Kampo has evolved in Japan, resulting in a system of medicine that has many differences from TCM. Kampo medicine is considered to be very safe; in Japan, Kampo herbal formulas are manufactured by licensed pharmaceutical companies, prescribed by Western-trained medical doctors (usually as a freeze-dried extract), and have quality control standards similar to those of prescription drugs. The present study examined Yokukan-san (Yi-Gan San in TCM), a Kampo formula that has been used empirically in Japan for more than 400 years. Accumulating clinical trials have demonstrated Yokukan-san's efficacy in treating patients with behavioral and psychological symptoms of dementia, which has resulted in the Japanese Society of Neurology listing it in the Japanese Guidelines for the Management of Dementia 2010. Efficacy in other diseases and conditions, such as sleep disorders, tardive dyskinesia, aggression, and impulsivity has also been reported. This article reviews both clinical and basic studies of Yokukan-san, with the goal of clarifying its clinical indications.

摘要

日本传统草药(汉方药)起源于中医(TCM)。它在六世纪中叶传入日本,并在与日本本土民间疗法结合后,经过 1400 多年的发展演变。汉方药虽然与 TCM 有一些相似之处,但在日本已经发展出了与 TCM 有许多不同的医学体系。汉方药被认为是非常安全的;在日本,汉方药方剂由持牌制药公司生产,由接受过西方培训的医生开处方(通常是冻干提取物),并具有类似于处方药的质量控制标准。本研究考察了日本使用了 400 多年的汉方方剂——六君子汤(在 TCM 中称为益肝散)。积累的临床试验表明,六君子汤在治疗行为和心理症状性痴呆患者方面具有疗效,这使得日本神经病学会在 2010 年的日本痴呆管理指南中列出了该方剂。在其他疾病和病症(如睡眠障碍、迟发性运动障碍、攻击性行为和冲动性)中的疗效也有报道。本文综述了六君子汤的临床和基础研究,旨在阐明其临床适应证。

相似文献

1
Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.
Neuropsychiatr Dis Treat. 2014 Sep 12;10:1727-42. doi: 10.2147/NDT.S65257. eCollection 2014.
3
Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):761-4. doi: 10.1016/j.pnpbp.2007.12.003. Epub 2007 Dec 14.
6
Kampo in women's health: Japan's traditional approach to premenstrual symptoms.
J Altern Complement Med. 2008 May;14(4):427-35. doi: 10.1089/acm.2007.7064.
7
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):150-4. doi: 10.1016/j.pnpbp.2007.07.026. Epub 2007 Aug 8.
8
Reviewing Kampo medicine (Traditional Japanese Herbal Medicine) for otology/neurotology diseases.
Auris Nasus Larynx. 2024 Feb;51(1):25-30. doi: 10.1016/j.anl.2023.04.009. Epub 2023 May 1.
9
Traditional Chinese medicine and Kampo: a review from the distant past for the future.
J Int Med Res. 2006 May-Jun;34(3):231-9. doi: 10.1177/147323000603400301.
10
Yi-gan san for treatment of charles bonnet syndrome (visual hallucination due to vision loss): an open-label study.
Clin Neuropharmacol. 2011 Jan-Feb;34(1):24-7. doi: 10.1097/WNF.0b013e318206785a.

引用本文的文献

2
Lifestyle Medicine and Japan's Longevity Miracle.
Am J Lifestyle Med. 2024 Mar 19;18(4):598-607. doi: 10.1177/15598276241234012. eCollection 2024 Jul-Aug.
3
Influence of Yokukansan on the refractive index of neuroblastoma cells.
Biomed Opt Express. 2023 Apr 10;14(5):1959-1973. doi: 10.1364/BOE.481169. eCollection 2023 May 1.
5
Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19.
Intern Med. 2022 Apr 1;61(7):1071-1076. doi: 10.2169/internalmedicine.9171-21. Epub 2022 Feb 1.
6
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer's Disease.
Drugs Aging. 2021 Nov;38(11):951-966. doi: 10.1007/s40266-021-00891-1. Epub 2021 Sep 27.
8
Excessive daytime sleepiness in adolescents: current treatment strategies.
Sleep Sci. 2020 Apr-Jun;13(2):157-171. doi: 10.5935/1984-0063.20190143.
10
A Review of the Clinical Evidence for Complementary and Alternative Medicine in Huntington's Disease.
Tremor Other Hyperkinet Mov (N Y). 2019 Aug 26;9. doi: 10.7916/tohm.v0.678. eCollection 2019.

本文引用的文献

1
A valid approach in refractory glossodynia: a single-institution 5-year experience treating with Japanese traditional herbal (kampo) medicine.
Evid Based Complement Alternat Med. 2013;2013:354872. doi: 10.1155/2013/354872. Epub 2013 Oct 7.
4
Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats.
J Ethnopharmacol. 2013 Aug 26;149(1):93-102. doi: 10.1016/j.jep.2013.06.005. Epub 2013 Jun 12.
6
Yokukansan (TJ-54) for treatment of very-late-onset schizophrenia-like psychosis: an open-label study.
Phytomedicine. 2013 May 15;20(7):654-8. doi: 10.1016/j.phymed.2013.01.007. Epub 2013 Feb 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验